Winton Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-25,773
Closed -$757K 1471
2020
Q2
$757K Buy
25,773
+7,715
+43% +$223K 0.02% 1077
2020
Q1
$486K Buy
+18,058
New +$539K 0.01% 1040
2018
Q4
Sell
-161,191
Closed -$11M 865
2018
Q3
$11M Buy
+161,191
New +$10.4M 0.23% 177
2017
Q1
Sell
-31,922
Closed -$1.18M 431
2016
Q4
$1.18M Buy
+31,922
New +$1.14M 0.04% 310

Other funds holding AVNS

Winton Group's AVNS Position: Q3 2020 in Review

Winton Group sold out of Avanos Medical (AVNS) in Q3 2020, closing a stake of 25,773 shares — an estimated $757K sold.

Winton Group first reported a position in AVNS in Q4 2016 and held it in 4 quarters. The position peaked at $11M in Q3 2018. 272 funds tracked by Wall St. Rank hold AVNS as of Q3 2020.

  • Winton Group reported no remaining Avanos Medical position as of Q3 2020 after selling out during the quarter.
  • Winton Group sold 25,773 Avanos Medical shares in Q3 2020, an estimated $757K.
  • Winton Group first reported a position in Avanos Medical in Q4 2016 and held it in 4 quarters.
  • Winton Group's Avanos Medical position peaked at $11M in Q3 2018.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2020.

Based on Winton Group's 13F filing for Q3 2020, filed 30 Oct 2020.